A system for dietary communications using intelligent systems regarding endocrinal measurements includes a computing device designed and configured to obtain a first endocrinal measurement relating to a user; compare the first endocrinal measurement to an endocrinal system effect; generate a body dysfunction label for the first endocrinal measurement as a function of the endocrinal system effect; identify a dietary communication as a function of the body dysfunction label, the first endocrinal measurement, and a first machine learning process, the first machine learning process trained using a first training set relating endocrinal measurements and body dysfunction labels to dietary communications; and present the dietary communication.

To provide a concentration measurement method that makes it possible to accurately, quickly, and non-destructively measure the concentration of a predetermined chemical component to a trace level of concentration by a simple means, that makes it possible to accurately and quickly measure the concentration of a chemical component within an object to be measured to a nano-order trace concentration level in real time, and that has a versatility which makes it possible to adapt said concentration measurement method to a variety of situations and embodiments. A time sharing method is used to irradiate an object to be measured with each of light of a first wavelength and light of a second wavelength having different light absorption rates with respect to the object to be measured, light of each of said wavelengths that arrives optically through the object to be measured as a result of irradiating with the light of each of said wavelengths is received by a shared light reception sensor, a signal relating to light of the first wavelength and a signal relating to light of the second wavelength are output from the light reception sensor in accordance with the received light and a differential signal of said signals is formed, and the concentration of a chemical component in the object to be measured is derived on the basis of the differential signal.

A method for identifying changes in an epilepsy patient's disease state, comprising: receiving at least one body data stream; determining at least one body index from the at least one body data stream; detecting a plurality of seizure events from the at least one body index; determining at least one seizure metric value for each seizure event; performing a first classification analysis of the plurality of seizure events from the at least one seizure metric value; detecting at least one additional seizure event from the at least one determined index; determining at least one seizure metric value for each additional seizure event, performing a second classification analysis of the plurality of seizure events and the at least one additional seizure event based upon the at least one seizure metric value; comparing the results of the first classification analysis and the second classification analysis; and performing a further action.

The present invention is directed to a system for recognition of biological alteration in human tissues using electromagnetic waves in the microwave range, the device comprising: a transmitter device (100) comprising at least one transmitting antenna (101), a transmitter (102), and a power supply (103); a receiving device (200) comprising at least one receiving antenna (201), a receiver (202), a pre-processing module (204), and a power supply (203); a microprocessor (301; 104) and a display (302; 105); wherein the transmitter device (100) and the receiving device (200) are configured to operate at a frequency comprised between 2.0 GHz and 3.0 GHz.

In a preferred embodiment, the operating frequency is comprised between 2.3 GHz and 2.5 GHz, and the device is suitable for the detection of a cancer in the human body, for example for the screening of prostate cancer, colorectal cancer, breast cancer, thyroid cancer.

The device according to the invention is capable of high sensitivity and accuracy of results and can detect not only the presence, but also the position of a cancer.

A system for dietary communications using intelligent systems regarding endocrinal measurements includes a computing device designed and configured to obtain a first endocrinal measurement relating to a user; compare the first endocrinal measurement to an endocrinal system effect; generate a body dysfunction label for the first endocrinal measurement as a function of the endocrinal system effect; identify a dietary communication as a function of the body dysfunction label, the first endocrinal measurement, and a first machine learning process, the first machine learning process trained using a first training set relating endocrinal measurements and body dysfunction labels to dietary communications; and present the dietary communication.

The present invention relates to endotracheal tubes for intra-operative monitoring of nerve and muscle tissue (neuromonitoring), a system for intra-operative neuromonitoring, a method for deriving stimulus responses in intra-operative neuromonitoring, and a method for classifying tissue types, having the purpose of preventing damage to nerves and muscles which run within the area of operation.

Wearable apparatus for monitoring various physiological and environmental factors are provided. Real-time, noninvasive health and environmental monitors include a plurality of compact sensors integrated within small, low-profile devices, such as earpiece modules. Physiological and environmental data is collected and wirelessly transmitted into a wireless network, where the data is stored and/or processed.

Improved methods and systems for diagnosing and for treating Cushing's syndrome and Cushing's Disease are provided herein, including methods and systems for concurrently treating Cushing's syndrome and differentially diagnosing Cushing's Disease from Ectopic Cushing's Syndrome in a patient with an established diagnosis of ACTH-dependent Cushing's syndrome. Treatment methods can use glucocorticoid receptor antagonists (GRAs), which differentially affect the ratio of cortisol to ACTH levels in patients having Cushing's Disease versus patients having Ectopic Cushing's Syndrome. Methods for concurrently treating and differentially diagnosing Cushing's Disease from Ectopic Cushing's Syndrome include obtaining baseline cortisol and ACTH levels of a patient, treating the patient with a GRA according to a protocol that would typically substantially elevate cortisol levels, obtaining post-treatment cortisol and ACTH levels of the patient, determining a differential relationship between baseline cortisol and ACTH levels and post-treatment cortisol and ACTH levels and providing a positive diagnosis based on the differential relationship.

The present application relates to a method of acquiring a side image for analyzing the degree of ocular proptosis. According to an embodiment, an image acquisition method is provided which is including: acquiring a front image of the subject's face while guidance is given to satisfy a first photographing condition; generating panorama guidance on the basis of position information of a first point and a second point extracted from the front image; providing guidance on movement of a photographing device to acquire a preview image corresponding to the panorama guidance; and acquiring a side image of the subject's face while guidance is given to satisfy a second photographing condition. The first captured image shows iris areas of the subject, and the second captured image shows an outer canthus and a cornea of one of the subject's eyes.

A system for sensing one or more physiological traits and obstetric conditions, such as a fertility phase, pregnancy, labor, post-partum conditions, and other conditions related to the reproductive system of the patient. The system may use the one or more physiological traits sensed to define one or more patient attributes for the patient, such as a hormone level, heart rate, blood pressure, respiration rate, temperature, oxygen saturation level, uterine contractions, fluid level, and/or other patient attributes. The system is configured to compare the one or more patient attributes to one or more attribute signs describing a threshold for the one or more patient attributes. The system is configured to issue a communication to the patient and/or a clinician based on the comparisons. The system may be configured to assess and indicate reproductive phases for the patient over a life-cycle from the fertility phase to the post-partum phase.